Evidence map›Paper›PMID 42087904›Full record

ArticleCMI communications2025

Clinical and Genomic Characterization of Serratia Bloodstream Infections.

Roberta Monardo, Lawrence P Park, Felicia Ruffin, Phillip Cox, An Q Dinh, Rachel E Korn, Parisa Farahani, Marco Ripa, Antonella Castagna, Blake M Hanson and 3 more

Abstract read
In one paragraph

Article in CMI communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Serratia Bacteraemia in the North Denmark Region: A Population-Based Study (2010-2024).APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2026
    Article
  2. From Environmental Organism to Nosocomial Threat:Antibiotics (Basel, Switzerland) · 2026
    Review
  3. Carbapenem-ResistantAntibiotics (Basel, Switzerland) · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Roberta MonardoDivision of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Lawrence P ParkDivision of Infectious Diseases, Duke University, Durham, North Carolina, USA.
Felicia RuffinDivision of Infectious Diseases, Duke University, Durham, North Carolina, USA.
Phillip CoxDivision of Infectious Diseases, Duke University, Durham, North Carolina, USA.
An Q DinhDepartment of Epidemiology, The UTHealth Houston School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Rachel E KornDivision of Infectious Diseases, Duke University, Durham, North Carolina, USA.
Parisa FarahaniDivision of Infectious Diseases, Duke University, Durham, North Carolina, USA.
Marco RipaDivision of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Antonella CastagnaDivision of Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Blake M HansonDepartment of Epidemiology, The UTHealth Houston School of Public Health, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Vance G FowlerDivision of Infectious Diseases, Duke University, Durham, North Carolina, USA.
Joshua T ThadenDivision of Infectious Diseases, Duke University, Durham, North Carolina, USA.
Stacey A MaskarinecDivision of Infectious Diseases, Duke University, Durham, North Carolina, USA.

Funding

HLA Fine Mapping to Elucidate S. aureus SusceptibilityR01AI165671 · NIAID · DUKE UNIVERSITY · PI FOWLER, VANCE G., SCOTT, WILLIAM K · 2021 to 2025
$3.8M
Staphylococcus aureus Cardiac Device Infections - From the Vascular ViewpointK23HL159275 · NHLBI · DUKE UNIVERSITY · PI Stacey A Maskarinec · 2022 to 2026
$897k
Characterization of a Novel E. coli Type III Secretion System Associated with Increased Patient MortalityK08AI171183 · NIAID · DUKE UNIVERSITY · PI Joshua T Thaden · 2022 to 2026
$895k
NHLBI NIH HHS K23 HL159275NIAID NIH HHS K08 AI171183NIAID NIH HHS R01 AI165671
6 · The paper itself

Abstract

Background: Previously considered a rare opportunistic pathogen, Methods: Patients were prospectively enrolled from 2002-2021 at Duke University. Characteristics and outcomes were compared among bacteremic patients due to Results: Of 2676 patients, 173 (6.5%) had Conclusion: Compared to other Enterobacterales, patients with

Indexed as

bacteremiadevice infectiongram-negativeSerratia marcescens

Identifiers

PMID42087904
PMCPMC13137315

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.